TroVax Renal Immunotherapy Survival Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to investigate whether TroVax, when added to first line standard of care therapy, improves survival for patients with locally advanced or metastatic clear cell renal adenocarcinoma.
Epistemonikos ID: 968c838f8354fa8baa7ac9224be635c0808636b1
First added on: Jul 16, 2020